National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 10) (PB 102 of 2017) (Cth)

PB 102 of 2017

National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 10)

National Health Act 1953

I, JULIANNE QUAINE, First Assistant Secretary (Acting), Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 13 December 2017

JULIANNE QUAINE

First Assistant Secretary (Acting)

Technology Assessment and Access Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 10).

(2)        This Instrument may also be cited as PB 102 of 2017.

2          Commencement

This Instrument commences on 1 January 2018.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1]Schedule 1, entry for Amoxycillin with Clavulanic Acid

omit:

Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL Oral Augmentin 1 1.60 4.81